Cigarette smoke-induced emphysema: A role for the B cell?

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 7, 2006, Pages 751-758

  Van Der Strate, Barry W A ^b   Postma, Dirkje S ^b   Brandsma, Corry Anke ^b   Melgert, Barbro N ^b   Luinge, Marjan A ^b   Geerlings, Marie ^b   Hylkema, Machteld N ^b   Van Den Berg, Anke ^b   Timens, Wim ^b   Kerstjens, Huib A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Autoimmunity; B cell; Chronic obstructive pulmonary disease; Emphysema; Inflammation

Indexed keywords

CIGARETTE SMOKE; IMMUNOGLOBULIN; NUCLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EMPHYSEMA; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG HOMOGENATE; LYMPH FOLLICLE; MOUSE; NONHUMAN; PARENCHYMA; PNEUMONIA; PRIORITY JOURNAL; SOMATIC MUTATION; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; DNA; GENES, IMMUNOGLOBULIN; HUMANS; LUNG; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; PULMONARY EMPHYSEMA; SMOKING;

EID: 33645321836     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200504-594OC     Document Type: Article

References (44)

1. National Heart Lung and Blood Institute, World Health Organization, Global Initiative for Chronic Obstructive Lung Disease. 2004 update: executive summary, global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Bethesda, MD: National Institutes of Health; 2004.
2. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996;51:348-350.
3. Tetley TD. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax 1993;48:560-565.
4. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): a consensus statement of the European Respiratory Society. Eur Respir J 1995;8:1398-1420.
5. Saetta M, Turato G, Facchini FM, Corbino L, Lucchini RE, Casoni G, Maestrelli P, Mapp CE, Ciaccia A, Fabbri LM. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 1997;156:1633-1639.
6. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-2004.
7. Ofulue AF, Ko M. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol 1999;277:L97-L105.
8. Churg A, Zay K, Shay S, Xie C, Shapiro SD, Hendricks R, Wright JL. Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am J Respir Cell Mol Biol 2002;27:368-374.
9. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F, Cavallesco G, Tropeano G, Mapp CE, Maestrelli P, et al. CD8+ cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:711-717.
10. de Jong JW, Belt-Gritter B, Koeter GH, Postma DS. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir Med 1997;91:67-76.
11. Turato G, Zuin R, Miniati M, Baraldo S, Rea F, Beghe B, Monti S, Formichi B, Boschetto P, Harari S, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002;166:105-110.
12. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653.
13. Bosken CH, Hards J, Gatter K, Hogg JC. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992;145:911-917.
14. van der Strate BWA, Hylkema MN, Postma DS, Timens W, Kerstjens HAM. Inflammatory changes and time course of emphysema induction in smoking C57/Bl6j mice [abstract]. Eur Respir J 2002;20:485S.
15. van der Strate BW, Postma DS, Luinge M, Geerlings M, Klok PA, Melgert BN, Hylkema MN, Timens W, Kerstjens HA. Inflammation in cigarette smoke induced emphysema in C57Bl/6 mice [abstract]. Am J Respir Crit Care Med 2003;167:A74.
16. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF, Timens W, Postma DS. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 1999;12:697-705.
17. Maggio EM, Stekelenburg E, Van den BA, Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 2001;94:60-66.
18. Griffith RB, Hancock R. Simultaneous mainstream-sidestream smoke exposure systems. I. Equipment and procedures. Toxicology 1985;34:123-138.
19. Griffith RB, Standafer S. Simultaneous mainstream-sidestream smoke exposure systems. II. The rat exposure system. Toxicology 1985;35:13-24.
20. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 1967;95:752-764.
21. Zubler RH. Naive and memory B cells in T-cell-dependent and T-independent responses. Springer Semin Immunopathol 2001;23:405-419.
22. Kroese FG, Timens W, Nieuwenhuis P. Germinal center reaction and B lymphocytes: morphology and function. Curr Top Pathol 1990;84:103-148.
23. Douglas MR, Morrison KE, Salmon M, Buckley CD. Why does inflammation persist: a dominant role for the stromal microenvironment. Expert Rev Mol Med 2002;2002:1-18.
24. Goya S, Matsuoka H, Mori M, Morishita H, Kida H, Kobashi Y, Kato T, Taguchi Y, Osaki T, Tachibana I, et al. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J Pathol 2003;200:82-87.
25. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000;106:1081-1093.
26. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-764.
27. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469-473.
28. Meshi B, Vitalis TZ, Ionescu D, Elliott WM, Liu C, Wang XD, Hayashi S, Hogg JC. Emphysematous lung destruction by cigarette smoke: the effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002;26:52-57.
29. Makela MJ, Nikkari S, Meurman O, Laine M, Arvilommi H. Virus-specific, antibody-secreting cells during upper respiratory infections. J Med Virol 1995;47:416-420.
30. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-721.
31. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-377.
32. Becker CG, Dubin T. Activation of factor XII by tobacco glycoprotein. J Exp Med 1977;146:457-467.
33. Phillips DH. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002;23:1979-2004.
34. Horton MR, Shapiro S, Bao C, Lowenstein CJ, Noble PW. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 1999;162:4171-4176.
35. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages: the role of HA size and CD44. J Clin Invest 1996;98:2403-2413.
36. Rafi A, Nagarkatti M, Nagarkatti PS. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 1997;89:2901-2908.
37. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003;24:19-24.
38. Magalhaes R, Stiehl P, Morawietz L, Berek C, Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002;441:415-427.
39. Berg L, Ronnelid J, Sanjeevi CB, Lampa J, Klareskog L. Interferon-γ production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLADQ8. Arthritis Res 2000;2:75-84.
40. Souto-Carneiro MM, Burkhardt H, Muller EC, Hermann R, Otto A, Kraetsch HG, Sack U, Konig A, Heinegard D, Muller-Hermelink HK, et al. Human monoclonal rheumatoid synovial B lymphocyte hybridoma with a new disease-related specificity for cartilage oligomeric matrix protein. J Immunol 2001;166:4202-4208.
41. Strassburg CP, Vogel A, Manns MP. Autoimmunity and hepatitis C. Autoimmun Rev 2003;2:322-331.
42. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koëter GH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000;55:12-18.
43. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001;17:946-953.
44. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003;58:832-834.